The DOI matches its Crossref record; 142 of the 142 references it cites were found in a registry or an index.
“Magic Chloro”: Profound Effects of the Chlorine Atom in Drug Discovery
Open accessAbstract
Chlorine is one of the most common atoms present in small-molecule drugs beyond carbon, hydrogen, nitrogen and oxygen. There are currently more than 250 FDA-approved chlorine-containing drugs, yet the beneficial effect of the chloro substituent has not yet been reviewed. The simple substitution of a hydrogen atom (R = H) with a chlorine atom (R = Cl) can result in incredible improvements in potency of up to 100,000-fold, and can lead to profound effects on pharmacokinetic parameters such as clearance, half-life, and drug exposure in vivo. Following the literature terminology of “magic methyl effect” in drugs, the term “magic chloro effect” has been coined herein. Reports of 500-fold or >1000-fold potency improvement are often serendipitous discoveries that can be considered “magic” rather than planned. However, hypotheses made to explain the magic chloro effect can lead to lessons that accelerate the cycle of drug discovery. With this in mind, we believe that medicinal chemists should place chlorine atoms into their lead scaffolds in judicious fashion, and organic chemists should invent more methods to place chlorine atoms selectively onto complex molecules.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CRC Handbook of Chemistry and Physics
(2016) · CRC Press eBooks · doi:10.1201/9781315380476 · Cited by 13,921
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
Fluorine in medicinal chemistry
Purser, S., Moore, P. R., Swallow, S., & Gouverneur, V. (2008) · Chem. Soc. Rev. · doi:10.1039/b610213c · Cited by 7,570
Natural products in drug discovery: advances and opportunities
Atanasov, A. G., Zotchev, S. B., Dirsch, V. M., Taskforce, T. I. N. P. S., Orhan, I. E., Banach, M., Rollinger, J. M., Barreca, D., Weckwerth, W., Bauer, R., et al. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00114-z · Cited by 5,392
Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
Lovering, F., Bikker, J., & Humblet, C. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901241e · Cited by 4,495
Understanding organofluorine chemistry. An introduction to the C–F bond
O'Hagan, D. (2008) · Chem. Soc. Rev. · doi:10.1039/b711844a · Cited by 4,045
Cavallo, G., Metrangolo, P., Milani, R., Pilati, T., Priimagi, A., Resnati, G., & Terraneo, G. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00484 · Cited by 4,035
Applications of Fluorine in Medicinal Chemistry
Gillis, E. P., Eastman, K. J., Hill, M. D., Donnelly, D. J., & Meanwell, N. A. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00258 · Cited by 3,618
Interactions with Aromatic Rings in Chemical and Biological Recognition
Meyer, E. A., Castellano, R. K., & Diederich, F. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200390319 · Cited by 3,541
Stereochemistry of organic compounds
Peakman, T. M. (1995) · Geochimica et Cosmochimica Acta · doi:10.1016/0016-7037(95)90151-5 · Cited by 2,920
Principles of early drug discovery
Hughes, J., Rees, S., Kalindjian, S., & Philpott, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01127.x · Cited by 2,859
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
Meanwell, N. A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1013693 · Cited by 2,854
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
Meanwell, N. A. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01788 · Cited by 2,655
The influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403
Contribution of Organofluorine Compounds to Pharmaceuticals
Inoue, M., Sumii, Y., & Shibata, N. (2020) · ACS Omega · doi:10.1021/acsomega.0c00830 · Cited by 1,944
Consistent van der Waals Radii for the Whole Main Group
Mantina, M., Chamberlin, A. C., Valero, R., Cramer, C. J., & Truhlar, D. G. (2009) · The Journal of Physical Chemistry A · doi:10.1021/jp8111556 · Cited by 1,866
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir034 · Cited by 1,599
A cartography of the van der Waals territories
Alvarez, S. (2013) · Dalton Transactions · doi:10.1039/c3dt50599e · Cited by 1,586
Aromatic Rings in Chemical and Biological Recognition: Energetics and Structures
Salonen, L. M., Ellermann, M., & Diederich, F. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201007560 · Cited by 1,539
Escape from Flatland 2: complexity and promiscuity
Lovering, F. (2013) · MedChemComm · doi:10.1039/c2md20347b · Cited by 1,444
Principles and Applications of Halogen Bonding in Medicinal Chemistry and Chemical Biology
Wilcken, R., Zimmermann, M. O., Lange, A., Joerger, A. C., & Boeckler, F. M. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm3012068 · Cited by 1,331
Bioisosterism: A Rational Approach in Drug Design
Patani, G. A., & LaVoie, E. J. (1996) · Chemical Reviews · doi:10.1021/cr950066q · Cited by 1,328
Aromatic substituent constants for structure-activity correlations
Hansch, C., Leo, A., Unger, S. H., Kim, K. H., Nikaitani, D., & Lien, E. J. (1973) · Journal of Medicinal Chemistry · doi:10.1021/jm00269a003 · Cited by 1,262
The role of ligand efficiency metrics in drug discovery
Hopkins, A. L., Keserü, G. M., Leeson, P. D., Rees, D. C., & Reynolds, C. H. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4163 · Cited by 1,181
Profound Methyl Effects in Drug Discovery and a Call for New CH Methylation Reactions
Schönherr, H., & Cernak, T. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201303207 · Cited by 1,094
The Methylation Effect in Medicinal Chemistry
Barreiro, E. J., Kümmerle, A. E., & Fraga, C. A. M. (2011) · Chemical Reviews · doi:10.1021/cr200060g · Cited by 1,017
Type IIA topoisomerase inhibition by a new class of antibacterial agents
Bax, B. D., Chan, P. F., Eggleston, D. S., Fosberry, A., Gentry, D. R., Gorrec, F., Giordano, I., Hann, M. M., Hennessy, A., Hibbs, M., et al. (2010) · Nature · doi:10.1038/nature09197 · Cited by 860
The role of fluorine in medicinal chemistry: Review Article
Shah, P., & Westwell, A. D. (2007) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756360701425014 · Cited by 799
On Outliers and Activity CliffsWhy QSAR Often Disappoints
Maggiora, G. M. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci060117s · Cited by 728
Chloroquine Resistance in Plasmodium falciparum Malaria Parasites Conferred by pfcrt Mutations
Sidhu, A. B. S., Verdier-Pinard, D., & Fidock, D. A. (2002) · Science · doi:10.1126/science.1074045 · Cited by 720
Molecular Recognition in Chemical and Biological Systems
Persch, E., Dumele, O., & Diederich, F. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201408487 · Cited by 654
Enzymatic pathways that regulate endocannabinoid signaling in the nervous system
Ahn, K., McKinney, M. K., & Cravatt, B. F. (2008) · Chemical Reviews · doi:10.1021/cr0782067 · Cited by 529
Systematic Investigation of Halogen Bonding in Protein–Ligand Interactions
Hardegger, L. A., Kuhn, B., Spinnler, B., Anselm, L., Ecabert, R., Stihle, M., Gsell, B., Thoma, R., Diez, J., Benz, J., et al. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201006781 · Cited by 492
Utilization of operational schemes for analog synthesis in drug design
Topliss, J. G. (1972) · Journal of Medicinal Chemistry · doi:10.1021/jm00280a002 · Cited by 457
The role of the medicinal chemist in drug discovery — then and now
Lombardino, J. G., & Lowe, J. A. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1523 · Cited by 452
Ertl, P., Altmann, E., & McKenna, J. M. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00754 · Cited by 429
Riley, K. E., Murray, J. S., Fanfrlík, J., Řezáč, J., Solá, R. J., Concha, M. C., Ramos, F. M., & Politzer, P. (2011) · Journal of Molecular Modeling · doi:10.1007/s00894-011-1015-6 · Cited by 405
de Béthune, M.-P. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2009.09.008 · Cited by 401
Smith, B. R., Eastman, C. M., & Njardarson, J. T. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501105n · Cited by 372
Structure−Activity Landscape Index: Identifying and Quantifying Activity Cliffs
Guha, R., & Van Drie, J. H. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci7004093 · Cited by 360
Lipophilic Efficiency as an Important Metric in Drug Design
Johnson, T. W., Gallego, R. A., & Edwards, M. P. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00077 · Cited by 349
Egan, T. J., Hunter, R., Kaschula, C. H., Marques, H. M., Misplon, A., & Walden, J. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990437l · Cited by 317
Fang, W., Ravindar, L., Rakesh, K. P., Manukumar, H. M. G., Shantharam, C. S., Alharbi, N. S., & Qin, H. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.03.063 · Cited by 317
Matched Molecular Pairs as a Medicinal Chemistry Tool: Miniperspective
Griffen, E., Leach, A. G., Robb, G. R., & Warner, D. J. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200452d · Cited by 282
Singh, R. K., Kumar, S., Prasad, D. N., & Bhardwaj, T. R. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.04.001 · Cited by 282
Kaschula, C. H., Egan, T. J., Hunter, R., Basilico, N., Parapini, S., Taramelli, D., Pasini, E., & Monti, D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020858u · Cited by 272
Sucralose metabolism and pharmacokinetics in man
Roberts, A., Renwick, A. G., Sims, J., & Snodin, D. J. (2000) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(00)00026-0 · Cited by 263
Hydrogen-Bond Donors in Drug Design
Kenny, P. W. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01147 · Cited by 241
Palau’chlor: A Practical and Reactive Chlorinating Reagent
Rodriguez, R. A., Pan, C.-M., Yabe, Y., Kawamata, Y., Eastgate, M. D., & Baran, P. S. (2014) · Journal of the American Chemical Society · doi:10.1021/ja5031744 · Cited by 237
C(sp 3 )–H methylation enabled by peroxide photosensitization and Ni-mediated radical coupling
Vasilopoulos, A., Krska, S. W., & Stahl, S. S. (2021) · Science · doi:10.1126/science.abh2623 · Cited by 227
A manual method for applying the Hansch approach to drug design
Topliss, J. G. (1977) · Journal of Medicinal Chemistry · doi:10.1021/jm00214a001 · Cited by 222
Chen, X., Kopecky, D. J., Mihalic, J., Jeffries, S., Min, X., Heath, J., Deignan, J., Lai, S., Fu, Z., Guimaraes, C., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300037x · Cited by 222
Heteroaromatic π-Stacking Energy Landscapes
Huber, R. G., Margreiter, M. A., Fuchs, J. E., von Grafenstein, S., Tautermann, C. S., Liedl, K. R., & Fox, T. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci500183u · Cited by 205
Halogens in Protein–Ligand Binding Mechanism: A Structural Perspective
Shinada, N. K., de Brevern, A. G., & Schmidtke, P. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01453 · Cited by 201
Relevance of Half-Life in Drug Design: Miniperspective
Smith, D. A., Beaumont, K., Maurer, T. S., & Di, L. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00969 · Cited by 199
C–H Methylation of Heteroarenes Inspired by Radical SAM Methyl Transferase
Gui, J., Zhou, Q., Pan, C.-M., Yabe, Y., Burns, A. C., Collins, M. R., Ornelas, M. A., Ishihara, Y., & Baran, P. S. (2014) · Journal of the American Chemical Society · doi:10.1021/ja5007838 · Cited by 197
Self-citationLahiri, S. D., Johnstone, M. R., Ross, P. L., McLaughlin, R. E., Olivier, N. B., & Alm, R. A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03057-14 · Cited by 197
Activity Landscape Representations for Structure−Activity Relationship Analysis
Wassermann, A. M., Wawer, M., & Bajorath, J. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100933w · Cited by 181
Evolving Concept of Activity Cliffs
Stumpfe, D., Hu, H., & Bajorath, J. (2019) · ACS Omega · doi:10.1021/acsomega.9b02221 · Cited by 181
The Impact of Artificial Sweeteners on Body Weight Control and Glucose Homeostasis
Pang, M. D., Goossens, G. H., & Blaak, E. E. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2020.598340 · Cited by 180
Clearance in Drug Design: Miniperspective
Smith, D. A., Beaumont, K., Maurer, T. S., & Di, L. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01263 · Cited by 177
Kuntz, K. W., Campbell, J. E., Keilhack, H., Pollock, R. M., Knutson, S. K., Porter-Scott, M., Richon, V. M., Sneeringer, C. J., Wigle, T. J., Allain, C. J., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01501 · Cited by 175
Harris, T. K., & Mildvan, A. S. (1999) · Proteins Structure Function and Bioinformatics · doi:10.1002/(sici)1097-0134(19990515)35:3<275::aid-prot1>3.0.co;2-v · Cited by 172
Abula, A., Xu, Z., Zhu, Z., Peng, C., Chen, Z., Zhu, W., & Aisa, H. A. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00898 · Cited by 160
Effects of Fluorine Substitution on Drug Metabolism: Pharmacological and Toxicological Implications
Park, B. K., & Kitteringham, N. R. (1994) · Drug Metabolism Reviews · doi:10.3109/03602539408998319 · Cited by 150
Maresca, A., & Supuran, C. T. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.06.040 · Cited by 144
Lipophilic Efficiency: The Most Important Efficiency Metric in Medicinal Chemistry
Freeman‐Cook, K. D., Hoffman, R. L., & Johnson, T. W. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.12.208 · Cited by 139
Pan, Y. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00235 · Cited by 134
Halogen Bonds Form the Basis for Selective P-TEFb Inhibition by DRB
Baumli, S., Endicott, J., & Johnson, L. N. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.07.012 · Cited by 132
Chiral Alkyl Halides: Underexplored Motifs in Medicine
Gál, B., Bucher, C., & Burns, N. Z. (2016) · Marine Drugs · doi:10.3390/md14110206 · Cited by 132
Hardegger, L. A., Kuhn, B., Spinnler, B., Anselm, L., Ecabert, R., Stihle, M., Gsell, B., Thoma, R., Diez, J., Benz, J., et al. (2011) · ChemMedChem · doi:10.1002/cmdc.201100353 · Cited by 131
McCarthy, J. S., Lotharius, J., Rückle, T., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30171-8 · Cited by 123
mmpdb: An Open-Source Matched Molecular Pair Platform for Large Multiproperty Data Sets
Dalke, A., Hert, J., & Krämer, C. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00173 · Cited by 123
Bistrović, A., Krstulović, L., Harej, A., Grbčić, P., Sedić, M., Koštrun, S., Pavelić, S. K., Bajić, M., & Raić‐Malić, S. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.10.061 · Cited by 118
Characterization of the Chemical Space of Known and Readily Obtainable Natural Products
Chen, Y., de Lomana, M. G., Friedrich, N., & Kirchmair, J. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00302 · Cited by 118
The Time and Place for Nature in Drug Discovery
Young, R. J., Flitsch, S. L., Grigalunas, M., Leeson, P. D., Quinn, R. J., Turner, N. J., & Waldmann, H. (2022) · JACS Au · doi:10.1021/jacsau.2c00415 · Cited by 113
Rational Design of Orthogonal Multipolar Interactions with Fluorine in Protein–Ligand Complexes
Pollock, J., Borkin, D., Lund, G., Purohit, T., Dyguda‐Kazimierowicz, E., Grembecka, J. E., & Cierpicki, T. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00975 · Cited by 111
Bootsma, A. N., Doney, A. C., & Wheeler, S. E. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b00936 · Cited by 110
Log D Contributions of Substituents Commonly Used in Medicinal Chemistry
Landry, M. L., & Crawford, J. J. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00489 · Cited by 101
Public Domain Databases for Medicinal Chemistry
Nicola, G., Liu, T., & Gilson, M. K. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300501t · Cited by 100
Murphy, C. D., & Sandford, G. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.1020295 · Cited by 93
Goldberg, F. W., Finlay, M. R. V., Ting, A. K. T., Beattie, D., Lamont, G. M., Fallan, C., Wrigley, G. L., Schimpl, M., Howard, M. R., Williamson, B., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01684 · Cited by 92
Chlorosulfolipids: Structure, synthesis, and biological relevance
Bedke, D. K., & Vanderwal, C. D. (2010) · Natural Product Reports · doi:10.1039/c0np00044b · Cited by 86
Yu, H., Hou, Z., Tian, Y., Mou, Y., & Guo, C. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.04.005 · Cited by 86
Bauer, M. R., Jones, R. N., Baud, M. G. J., Wilcken, R., Boeckler, F. M., Fersht, A. R., Joerger, A. C., & Spencer, J. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00315 · Cited by 83
Kulokekahilide-2, a Cytotoxic Depsipeptide from a Cephalaspidean Mollusk Philinopsis speciosa
Nakao, Y., Yoshida, W. Y., Takada, Y., Kimura, J., Liu, Y., Mooberry, S. L., & Scheuer, P. J. (2004) · Journal of Natural Products · doi:10.1021/np049949f · Cited by 82
Lead Optimization of 3-Carboxyl-4(1H)-Quinolones to Deliver Orally Bioavailable Antimalarials
Zhang, Y., Clark, J. A., Connelly, M., Zhu, F., Min, J., Guiguemde, W. A., Pradhan, A., Iyer, L., Furimsky, A. M., Gow, J. M., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201642z · Cited by 82
London Dispersion Helps Refine Steric A-Values: Dispersion Energy Donor Scales
Solel, E., Ruth, M., & Schreiner, P. R. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c09222 · Cited by 82
The host targeting effect of chloroquine in malaria
Coban, C. (2020) · Current Opinion in Immunology · doi:10.1016/j.coi.2020.07.005 · Cited by 81
Mottishaw, J. D., Erck, A., Kramer, J. H., Sun, H., & Koppang, M. D. (2015) · Journal of Chemical Education · doi:10.1021/ed5006344 · Cited by 77
Matched Molecular Pair Analysis: Significance and the Impact of Experimental Uncertainty
Krämer, C., Fuchs, J. E., Whitebread, S., Gedeck, P., & Liedl, K. R. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500317a · Cited by 77
Okaniwa, M., Hirose, M., Imada, T., Ohashi, T., Hayashi, Y., Miyazaki, T., Arita, T., Yabuki, M., Kakoi, K., Kato, J., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300126x · Cited by 75
Kung, P., Rui, E. Y., Bergqvist, S., Bingham, P., Braganza, J., Collins, M. R., Cui, M., Diehl, W. C., Dinh, D. M., Fan, C., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00515 · Cited by 74
Structure–activity Relationships of Glutathione Peroxidase 4 Inhibitor Warheads
Eaton, J. K., Furst, L., Cai, L. L., Viswanathan, V. S., & Schreiber, S. L. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127538 · Cited by 73
Contribution to investigation of antimicrobial activity of styrylquinolines
Cieślik, W., Musioł, R., Nycz, J. E., et al. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.10.027 · Cited by 72
Metabolism and Toxicity of Fluorine Compounds
Kyzer, J. L., & Martens, M. (2021) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00439 · Cited by 71
Brown, D. G., Gagnon, M. M., & Boström, J. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501894t · Cited by 70
Advances in exploring activity cliffs
Stumpfe, D., Hu, H., & Bajorath, J. (2020) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-020-00315-z · Cited by 70
Engers, J. L., Rodriguez, A. L., Konkol, L. C., Morrison, R. D., Thompson, A. D., Byers, F. W., Blobaum, A. L., Chang, S., Venable, D. F., Loch, M. T., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01005 · Cited by 68
Hammill, J. T., Bhasin, D., Scott, D. C., Min, J., Chen, Y., Lü, Y., Yang, L., Kim, H. S., Connelly, M., Hammill, C. V., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01282 · Cited by 66
Evolution of Nitrogen-Based Alkylating Anticancer Agents
Lehmann, F., & Wennerberg, J. (2021) · Processes · doi:10.3390/pr9020377 · Cited by 64
Salonen, L. M., Holland, M. C., Kaib, P. S. J., Haap, W. J., Benz, J., Mary, J., Kuster, O., Schweizer, W. B., Banner, D. W., & Diederich, F. (2011) · Chemistry - A European Journal · doi:10.1002/chem.201102571 · Cited by 63
Chen, J., Levant, B., Jiang, C., Keck, T. M., Newman, A. H., & Wang, S. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401798r · Cited by 59
Pauk, K., Zadražilová, I., Imramovský, A., Vinšová, J., Pokorná, M., Masaříková, M., Čížek, A., & Jampílek, J. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.08.029 · Cited by 57
From Activity Cliffs to Activity Ridges: Informative Data Structures for SAR Analysis
Vogt, M., Huang, Y., & Bajorath, J. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci2002473 · Cited by 57
Rational Design of Potent Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase
Chong, P. Y., Sebahar, P. R., Youngman, M., Garrido, D. M., Zhang, H., Stewart, E. L., Nolte, R. T., Wang, L., Ferris, R. G., EDELSTEIN, M. P., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301294g · Cited by 56
Kantsadi, A. L., Hayes, J. M., Manta, S., Skamnaki, V. T., Kiritsis, C., Psarra, A. G., Koutsogiannis, Z., Dimopoulou, A., Theofanous, S., Nikoleousakos, N., et al. (2012) · ChemMedChem · doi:10.1002/cmdc.201100533 · Cited by 52
Petri, L., Egyed, A., Bajusz, D., Imre, T., Hetényi, A., Martinek, T. A., Ábrányi‐Balogh, P., & Keserű, G. M. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112836 · Cited by 51
Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition
Papa, A., Pasquini, S., Contri, C., Gemma, S., Campiani, G., Butini, S., Varani, K., & Vincenzi, F. (2022) · Cells · doi:10.3390/cells11030471 · Cited by 51
Silveira, F. F., de Souza, J. O., Hoelz, L. V. B., Campos, V. R., Jabor, V. A. P., Aguiar, A. C. C., Nonato, M. C., Albuquerque, M. G., Guido, R. V. C., Boechat, N., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112941 · Cited by 47
Davies, D. T., Leiris, S. J., Zalacaín, M., Sprynski, N., Castandet, J., Bousquet, J., Lozano, C., Llanos, A., Alibaud, L., Vasa, S., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01535 · Cited by 47
Crystal structure of PI3Kgamma with a dihydropurinone inhibitor (compound 4)
Petersen, J., Oster, L., Schimpl, M., Goldberg, F. W., Finlay, M. R. V., Ting, A. K. T., Beattie, D., Lamont, G. M., Fallan, C., Wrigley, G. L., et al. (2019) · Worldwide Protein Data Bank · doi:10.2210/pdb6t3b/pdb · Cited by 46
Kahl, D., Hutchings, K. M., Lisabeth, E. M., Haak, A. J., Leipprandt, J. R., Dexheimer, T. S., Khanna, D., Tsou, P., Campbell, P. L., Fox, D. A., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01772 · Cited by 43
Hoveyda, H. R., Fraser, G. L., Roy, M., Dutheuil, G., Batt, F., Bousmaqui, M. E., Korac, J., Lenoir, F., Lapin, A., Noël, S., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm5017413 · Cited by 42
Kruszyk, M. M., Jessing, M., Kristensen, J. L., & Jørgensen, M. (2016) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.6b00584 · Cited by 42
Structure–Activity Relationships of Small Molecule Autotaxin Inhibitors with a Discrete Binding Mode
Miller, L., Keune, W., Castagna, D., Young, L., Duffy, E., Potjewyd, F., Salgado-Polo, F., Garcia, P. E., Semaan, D., Pritchard, J. M., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01597 · Cited by 40
Gehrke, S. S., Pinto, É. G., Steverding, D., Pleban, K., Tempone, A. G., Hider, R. C., & Wagner, G. K. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.11.009 · Cited by 39
Garai, S., Leo, L. M., Szczesniak, A.-M., Hurst, D. P., Schaffer, P. C., Zagzoog, A., Black, T., Deschamps, J. R., Miess, E., Schulz, S., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00040 · Cited by 38
Parallel Worlds of Public and Commercial Bioactive Chemistry Data
Lipinski, C. A., Litterman, N. K., Southan, C., Williams, A. J., Clark, A. M., & Ekins, S. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5011308 · Cited by 36
Liu, K., Li, D., Zheng, W., Shi, M., Chen, Y. X., Tang, M., Yang, T., Zhao, M., Deng, D., Zhang, C., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00004 · Cited by 35
Manvich, D. F., Petko, A. K., Branco, R. C., Foster, S. L., Porter‐Stransky, K. A., Stout, K. A., Newman, A. H., Miller, G. W., Paladini, C. A., & Weinshenker, D. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0371-2 · Cited by 34
Halogen Bonds Exist between Noncovalent Ligands and Natural Nucleic Acids
Mu, K., Zhu, Z., Abula, A., Peng, C., Zhu, W., & Xu, Z. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01854 · Cited by 34
Stacking Interactions between 9-Methyladenine and Heterocycles Commonly Found in Pharmaceuticals
An, Y., Doney, A. C., Andrade, R. B., & Wheeler, S. E. (2016) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00651 · Cited by 31
Natural product-informed exploration of chemical space to enable bioactive molecular discovery
Nelson, A. S., & Karageorgis, G. (2020) · RSC Medicinal Chemistry · doi:10.1039/d0md00376j · Cited by 31
Shamovsky, I. L., de Graaf, C., Alderin, L., Bengtsson, M., Bladh, H., Börjesson, L., Connolly, S., Dyke, H. J., van den Heuvel, M., Johansson, H., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900713y · Cited by 28
Krautwald, S., Nilewski, C., Mori, M., Shiomi, K., Ōmura, S., & Carreira, E. M. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201511672 · Cited by 28
Investigation into the functional impact of the vancomycin C-ring aryl chloride
Pinchman, J. R., & Boger, D. L. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.06.080 · Cited by 26
Screening of a Halogen-Enriched Fragment Library Leads to Unconventional Binding Modes
Dammann, M., Stahlecker, J., Zimmermann, M. O., Klett, T., Rotzinger, K., Krämer, M., Coles, M. P., Stehle, T., & Boeckler, F. M. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00951 · Cited by 26
Shiokawa, Z., Hashimoto, K., Saito, B., Oguro, Y., Sumi, H., Yabuki, M., Yoshimatsu, M., Kosugi, Y., Debori, Y., Morishita, N., et al. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.09.067 · Cited by 24
Kobayakawa, T., Matsuzaki, Y., Hozumi, K., Nomura, W., Nomizu, M., & Tamamura, H. (2017) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.7b00234 · Cited by 23
Yang, Z., Fang, Y., Pham, T.-A. N., Lee, J., & Park, H. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.12.011 · Cited by 21
de Vicente, J., Tivitmahaisoon, P., Berry, P., Bolin, D. R., Carvajal, D. M., He, W., Huang, K., Janson, C. A., Liang, L., Lukacs, C., et al. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00251 · Cited by 20
Design of novel nicotinamides as potent and selective monoamine oxidase a inhibitors
Shi, L., Yang, Y., Li, Z.-L., Zhu, Z.-W., Liu, C., & Zhu, H. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.12.065 · Cited by 18
Umehara, M., Negishi, T., Tashiro, T., Nakao, Y., & Kimura, J. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.10.058 · Cited by 16
Jaiswal, S., & Ayyannan, S. R. (2021) · ChemMedChem · doi:10.1002/cmdc.202100559 · Cited by 14
Rai, D., Chen, W., Tian, Y. E., Chen, X., Zhan, P., Clercq, E. D., Pannecouque, C. C., Balzarini, J. M., & Liu, X. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.09.051 · Cited by 13
Dounay, A. B., Barta, N. S., Campbell, B. M., Coleman, C., Collantes, E. M., Denny, L. I., Dutta, S., Gray, D. L., Hou, D., Iyer, R., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.12.023 · Cited by 11
3-Aryl-3-arylmethoxyazetidines. A new class of high affinity ligands for monoamine transporters
Thaxton-Weissenfluh, A., Izenwasser, S., Wade, D., Stevens, E. D., Mobley, D. L., Jaber, V. R., Lomenzo, S. A., & Trudell, M. L. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.05.071 · Cited by 10
Barbaro, L., Rodriguez, A. L., Blevins, A., Dickerson, J. W., Billard, N. B., Boutaud, O. G., Rook, J. L., Niswender, C. M., Conn, P. J., Engers, D. W., et al. (2021) · ACS Bio & Med Chem Au · doi:10.1021/acsbiomedchemau.1c00024 · Cited by 9
The quest for magic: recent advances in C(sp3)–H methylation
Feng, K. (2022) · Pure and Applied Chemistry · doi:10.1515/pac-2021-1203 · Cited by 5
Pan, C., Ishihara, Y., & Baran, P. S. (2016) · Encyclopedia of Reagents for Organic Synthesis · doi:10.1002/047084289x.rn01901 · Cited by 2
Self-citation
Cited by
Selective and Potent Molecular Glue Degraders for NIMA‐Related Kinase 7
Chen, L., Huang, L., Wen, W., Zeng, P., Wu, Y., Han, Q., Chen, X., Guo, Z., Yu, H., Lu, W., et al. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202500169 · Cited by 24
Metadata
- Authors
- Chiodi, D., & Ishihara, Y.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2023-04-04
- Volume
- 66
- Issue
- 8
- Pages
- 5305-5331
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W4362596569
- Cited by
- 263
- References
- 142
- FWCI
- 34.35
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.